Latest resources and news surrounding Novartis data featured at the 63nd American Society of Hematology Annual Meeting (ASH). Nov 29, 2021 Press release New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio Redefining what it means to live with blood disorders: